A detailed history of Rothschild Investment LLC transactions in Novavax Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 290 shares of NVAX stock, worth $2,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares
290
Previous 330 12.12%
Holding current value
$2,021
Previous $2.08 Million 20.92%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

SELL
$6.56 - $9.71 $262 - $388
-40 Reduced 12.12%
290 $2.51 Million
Q2 2025

Aug 11, 2025

BUY
$5.43 - $7.74 $543 - $774
100 Added 43.48%
330 $2.08 Million
Q1 2025

Apr 08, 2025

BUY
$6.41 - $10.82 $544 - $919
85 Added 58.62%
230 $1.47 Million
Q4 2024

Feb 04, 2025

BUY
$7.22 - $14.68 $108 - $220
15 Added 11.54%
145 $1.17 Million
Q3 2024

Oct 18, 2024

BUY
$10.71 - $17.11 $856 - $1,368
80 Added 160.0%
130 $1.64 Million
Q2 2024

Jul 30, 2024

BUY
$3.89 - $20.97 $194 - $1,048
50 New
50 $633,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $545M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.